Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 6902744 Exendin agonist formulations and methods of administration thereof

Patent 6902744 was granted and assigned to Amylin Pharmaceuticals on June, 2005 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

Amylin Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Orville G. Kolterman0

Andrew A. Young0

Date of Patent

June 7, 2005

0

Patent Application Number

098893300

Date Filed

January 14, 2000

0

Patent Citations Received

US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof

0

0

US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)

0

US Patent 12071516 Polymeric stabilizing formulations

0

US Patent 12060430 Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)

0

US Patent 11884713 Acylated glucagon analogues

0

Patent Primary Examiner

Karen Cochrane Carlson

0

Patent abstract

Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6902744 Exendin agonist formulations and methods of administration thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool